NASDAQ:ZYNE - Zynerba Pharmaceuticals Insider Trading Activity

$11.47
-0.69 (-5.67 %)
(As of 07/23/2019 10:02 AM ET)
Today's Range
$11.37
Now: $11.47
$12.15
50-Day Range
$10.65
MA: $13.08
$15.57
52-Week Range
$2.75
Now: $11.47
$16.47
Volume3,196 shs
Average Volume1.47 million shs
Market Capitalization$241.79 million
P/E RatioN/A
Dividend YieldN/A
Beta4.88

Insider Trades

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Insider Buying and Selling Activity

Insider Ownership Percentage: 10.79%

Zynerba Pharmaceuticals (NASDAQ ZYNE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2018John P ButlerDirectorBuy5,000$6.43$32,150.005,000View SEC Filing  
8/6/2018Armando AnidoChairmanBuy15,000$5.96$89,400.00352,512View SEC Filing  
8/6/2018James E FickenscherCFOBuy8,518$5.97$50,852.4620,718View SEC Filing  
8/6/2018Terri B SebreePresidentBuy3,800$5.79$22,002.00182,546View SEC Filing  
5/30/2018Michael RappMajor ShareholderBuy5,885$10.45$61,498.25View SEC Filing  
5/2/2018Michael RappMajor ShareholderBuy15,000$10.46$156,900.00View SEC Filing  
3/22/2018Michael RappMajor ShareholderBuy10,000$9.28$92,800.00View SEC Filing  
1/2/2018Michael RappMajor ShareholderBuy15,000$12.99$194,850.00View SEC Filing  
10/23/2017Michael RappMajor ShareholderBuy25,745$9.94$255,905.30View SEC Filing  
10/19/2017Michael RappMajor ShareholderBuy44,255$9.59$424,405.45View SEC Filing  
5/15/2017Armando AnidoChairmanBuy5,000$19.70$98,500.00336,012View SEC Filing  
5/12/2017James E FickenscherCFOBuy5,200$19.82$103,064.0012,200View SEC Filing  
12/29/2016Michael RappMajor ShareholderBuy10,000$15.85$158,500.001,354,115View SEC Filing  
12/7/2016James E FickenscherCFOBuy7,000$14.08$98,560.003,000View SEC Filing  
8/16/2016Suzanne M HanlonInsiderSell3,000$10.53$31,590.0039,893View SEC Filing  
(Data available from 1/1/2013 forward)
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Featured Article: Futures Contract

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel